4//SEC Filing
Onaitis Matthew 4
Accession 0001209191-13-001584
CIK 0001339455other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 7:01 PM ET
Size
5.5 KB
Accession
0001209191-13-001584
Insider Transaction Report
Form 4
Onaitis Matthew
VP, General Counsel
Transactions
- Award
Common Stock
2012-12-31+1,494→ 54,837 total
Footnotes (1)
- [F1]These RSUs were granted in lieu of a portion of the Participant's salary from the quarter ended December 31, 2012. Subject to the terms of the Restricted Stock Unit Agreement, 100% of the RSU Award shall vest upon the earlier of (a) the time that is immediately prior to the consummation of the merger contemplated by the Agreement and Plan of Merger by and among the Company, Pernix Therapeutics Holdings, Inc. and Pernix Acquisition Corp. I dated as of December 10, 2012 (the "Merger Agreement"), or (b) the first date included within an open trading window under the Company's Insider Trading Policy following any termination of the Merger Agreement, subject in either case to Participant's continued status as an Employee, Independent Director or Consultant (each as defined in the Plan) of the Company or any Subsidiary on such vesting date.
Documents
Issuer
Somaxon Pharmaceuticals, Inc.
CIK 0001339455
Entity typeother
Related Parties
1- filerCIK 0001362822
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 7:01 PM ET
- Size
- 5.5 KB